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Abstract
Background: Members of the Paired-like homeodomain transcription factor (PITX) gene family,
particularly PITX1 and PITX2, play important roles in normal development and in differentiated cell
functions. Three major isoforms of PITX2 were previously reported to be produced through both
alternative mRNA splicing (PITX2A and PITX2B) and alternative promoter usage (PITX2C). The
proteins derived from these mRNAs contain identical homeodomain and carboxyl termini.
Differences in the amino-termini of the proteins may confer functional differences in some
contexts.
Results: Here, we report the identification of two novel PITX2 isoforms. First, we demonstrate
that the Pitx2c mRNA generates two protein products, PITX2Cα and PITX2Cβ, via alternative
translation initiation. Second, we identified a novel mRNA splice variant, Pitx2b2, which uses the
same 5' splice donor in intron 2 as Pitx2b (hereafter referred to as Pitx2b1), but employs an
alternative 3' splice acceptor, leading to an in-frame deletion of 39 base pairs relative to Pitx2b1.
Pitx2b2 mRNA is expressed in both murine and human pituitary. The data show that in a murine
gonadotrope cell line and adult murine pituitary what was previously thought to be PITX2B1 is
actually PITX2Cβ, or perhaps PITX2B2. PITX2B1 is expressed at lower levels than previously
thought. PITX2Cβ and PITX2B2 activate gonadotrope-specific gene promoter-reporters similarly
to known PITX2 isoforms.
Conclusion: We have identified and characterized two novel isoforms of PITX2, generated by
alternative translation initiation (PITX2Cβ) and alternative mRNA splicing (PITX2B2). These
proteins show similar DNA binding and trans-activation functions as other PITX2 isoforms in vitro,
though their conservation across species suggests that they may play distinct, as yet unidentified,
roles in vivo.
Background
Homeobox genes play fundamental roles in develop-
ment, including patterning and cell fate determination,
and in cell-specific gene expression in adults [1]. PITX2
along with PITX1 and PITX3 form the PITX/RIEG sub-
family of the Paired-like class of homeobox proteins [2-6].
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PITX2  (also known as RIEG1  or  ARP1) was originally
cloned from a human craniofacial cDNA library and was
found to be mutated in patients with Axenfeld-Rieger syn-
drome (ARS) [6]. ARS is an autosomal-dominant disorder
of morphogenesis, characterized by malformations of the
eyes, teeth, and umbilicus [6-8]. The murine gene was
cloned independently by several groups and assigned var-
ious names (Rieg,  Ptx2, Otlx2, Brx1) [3,5,6,8-10]. The
Pitx2/PITX2 gene is highly conserved across species. The
human and murine coding regions share 91% nucleotide
(and 99.2% protein) sequence identity (PITX2A isoform,
see more below) [3,6].
During murine embryonic development, Pitx2  is
expressed in the heart, eye, pituitary, teeth, tongue, maxil-
lary and mandibular epithelia, and in certain regions of
the developing central nervous system [11-13]. Expres-
sion in the eye, dental lamina and umbilicus is consistent
with a role for mutations in PITX2 in the pathogenesis of
ARS. Additionally, Pitx2 is expressed in the lateral plate
mesoderm and is expressed asymmetrically in several
organs, contributing to differences in left-right patterning
during embryonic development [5,14,15]. Pitx2-deficient
mice exhibit failure of body-wall closure, arrest in organ
turning, ocular defects, right pulmonary isomerism,
altered cardiac position, and perturbations in early deter-
mination events in anterior pituitary gland and tooth org-
anogenesis [12,16-18]. Mice with complete Pitx2 loss-of-
function mutations die by embryonic day 15 due to severe
heart, craniofacial and pituitary gland defects [12,19].
The PITX2 gene can generate different protein isoforms in
humans and other mammals, the most thoroughly char-
acterized of which are PITX2A, PITX2B, and PITX2C.
Orthologs of these proteins have also been described in
other vertebrates such as zebrafish, Xenopus and chicken
[20-22]. Another mRNA isoform, PITX2D, was recently-
cloned from a human craniofacial cDNA library [23]. The
PITX2  gene in human and mouse is comprised of six
exons. PITX2A and PITX2B mRNAs are produced through
alternative splicing of the same pre-mRNA. The PITX2A
isoform contains exons 1, 2, 5 and 6 (Fig. 1). PITX2B is
identical to PITX2A, but retains an additional exon, exon
3 (138 bp), and thereby has a longer N-terminus (Fig. 1).
PITX2C  is transcribed from an alternative promoter
upstream of exon 4, and therefore has a unique N-termi-
nus, but shares its homeodomain (HD) and carboxyl ter-
minus with the other two PITX2 isoforms (Fig. 1). In
human and mouse, the PITX2A, PITX2B, and PITX2C pro-
teins are 271, 317 and 324 amino acids in length, contain-
ing 233 common amino acids encoding the
homeodomain (HD) and C-termini [3,8,11,12,19,23].
PITX2D derives from the same promoter as PITX2C, but is
alternatively spliced at a cryptic 3' splice acceptor site
within exon 5, and thus has a truncated HD [23]. The
PITX2D mRNA has not been described in other species.
During development, the different PITX2 isoforms show
both overlapping and distinct patterns of expression. Both
the qualitative (where) and quantitative (how much)
nature of their expression are critical to normal vertebrate
development [17,22,24,25]. In adults, PITX2 proteins act
as transcriptional regulators. In vitro studies show that all
Schematic representation of the major isoforms of PITX2 in mouse and human Figure 1
Schematic representation of the major isoforms of PITX2 in mouse and human. The PITX2 gene consists of 6 
exons, which are depicted as boxes. The introns and flanking sequences are represented as lines connecting the boxes. The 
unfilled and filled boxes represent the non-coding and coding sequences, respectively. The homeodomain is indicated as a black 
region spanning exons 5 and 6. The solid line joins the exons present in PITX2A (top) and PITX2B (bottom) mRNAs; the broken 
line connects the exons present in the PITX2C mRNA. PITX2D is not pictured.BMC Molecular Biology 2008, 9:31 http://www.biomedcentral.com/1471-2199/9/31
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the three isoforms can trans-activate a variety of genes,
including procollagen lysyl hydroxylase 1, atrial natriu-
retic factor, prolactin, follicle-stimulating hormone β
(Fshb), and luteinizing hormone β ( Lhb) [23,26-28].
Because of its truncated HD, PITX2D does not bind DNA
but inhibits the transcriptional activity of other isoforms
through direct physical interaction [23].
Several groups, including ours, have been investigating
functional roles for PITX2 proteins in anterior pituitary
cells [18,26,29-32]. Pitx2 is required at several different
stages of pituitary development with roles in early progen-
itor cell formation and later lineage specification of soma-
totrope, lactotrope, thyrotrope and gonadotrope lineages
[5,19,33,34]. PITX2 proteins are expressed in all hormone
secreting cell types of the mature anterior lobe with the
exception of corticotropes [5,35]. In fact, these proteins
have been described as pan-pituitary transcriptional regu-
lators of various hormone-encoding genes [27,30]. In the
context of our recent work on PITX protein regulation of
Fshb transcription [32], we identified two novel PITX2 iso-
forms. Here, we describe their characterization and exam-
ine their functions relative to the previously identified
PITX2 isoforms.
Results and Discussion
Alternative translation initiation sites in the Pitx2c mRNA 
give rise to two proteins
During the course of our studies on transcriptional regu-
lation of Fshb gene by PITX proteins in a murine gonado-
trope cell line [32], we observed more than the expected
three PITX2 immunoreactive proteins on western blot
analyses (see Fig. 3D, left lane). We also consistently
observed two PITX2 immunoreactive proteins derived
from a murine PITX2C expression vector transfected into
heterologous CHO cells (see Fig. 2C, lane 1). Both of
these proteins bound to a PITX binding site in the murine
Fshb promoter in southwestern blot analysis [32], suggest-
ing that neither product was an artifact of the expression
system. A review of the literature indicated that a human
PITX2C expression construct similarly generated two pro-
teins, though the nature of these proteins was not
explored [23].
We therefore hypothesized that the Pitx2c mRNA contains
alternative translation initiation codons. We examined
the murine Pitx2c open-reading frame (ORF) (GenBank
accession nos. AF048724 and NM_001042502) for down-
stream AUG codons in-frame with the canonical start site
and observed two: Met4 and Met35. During translation,
small ribosomal subunits enter at the 5'-end of the mRNA
and migrate linearly until they encounter the first AUG
codon (for review see [36]). In higher eukaryotes, the
stop-scanning step is modulated by sequences flanking
the AUG. In mammals, the optimal consensus sequence,
GCCRCCAUGG (R = purine; start codon is underlined
and italicized), has been identified as the most efficient
context for translation initiation [36-38]. Mutations that
perturb the consensus sequence, especially those that sub-
stitute a pyrimidine for a purine at position -3 (relative to
the AUG), cause some 40S subunits to bypass the first
AUG and continue their search for an AUG in more favo-
rable context for translation initiation. This leaky ribos-
omal scanning is even more pronounced when the G at
position +4 (the first base 3' of the AUG) is also altered.
AUGSTART codons are therefore designated strong (R-3 and
G+4) or weak based on conformity to the consensus
sequence at positions -3 and +4 [36,39].
In the murine Pitx2c ORF, the nucleotides flanking the
codons for Met1 and Met4 do not match the consensus
sequence and thus provide a weak context for translation
initiation (Fig. 2A, -3 and +4 are marked with dashed
boxes). However, the AUG encoding Met35 is flanked by
a strong consensus sequence due to presence of Gs at posi-
tions -3 and +4 (Fig. 2A, boxes with solid lines). We pre-
dicted that the shorter form of PITX2C (hereafter
PITX2Cβ) is initiated from Met35 and the longer (canon-
ical) form (hereafter PITX2Cα) from Met1. To evaluate
this hypothesis, we introduced point mutations into the
wild-type (WT) PITX2C expression construct (Fig. 2B).
Briefly, we changed the downstream Met35 to Leu (M35L)
to confirm that the faster mobility isoform was initiated at
this amino acid and to generate a construct that expresses
PITX2Cα exclusively. As predicted, the mutation elimi-
nated PITX2Cβ (Fig. 2C, lane 2). To show that the weak
initiation context of Met1 permits leaky ribosomal scan-
ning, we replaced the thymine (T; corresponding to uracil
in mRNA) at the -3 position with an adenine (T-3A).
Indeed, this construct expressed PITX2Cα more and
PITX2Cβ less abundantly than WT (Fig. 2C, compare
lanes 1 and 3); however, some of the PITX2Cβ isoform
was retained. Therefore, this single base change was not
sufficient to stop leaky scanning altogether. This is likely
because the +4 base was still less than optimal. Because
this was the first base of codon 2, we could not change it
without making a non-conservative amino acid substitu-
tion (Asn, AAC, to Asp, GAC). Because the T-3A mutation
increased the abundance of PITX2Cα, it is likely that
translation of this isoform occurs from Met1 and not
Met4; however, this needs to be confirmed experimentally
(e.g., by N-terminal sequencing of endogenous PITX2C).
To make a PITX2Cβ expression construct, we mutated
Leu5 to a non-sense codon (L5Stop), thus terminating the
protein translated from Met1 (or Met4) prematurely. This
construct produced the PITX2Cβ isoform exclusively and
at a level equal to that from the WT construct (Fig. 2C,
compare lanes 1 and 5). These data further confirmed that
translation initiation could occur from Met35. For down-BMC Molecular Biology 2008, 9:31 http://www.biomedcentral.com/1471-2199/9/31
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stream applications comparing functional differences
between the two isoforms, we generated a construct that
produced PITX2Cα exclusively and at a level comparable
to that of PITX2Cβ by introducing both the M35L and T-
3A mutations (Fig. 2C, lane 4).
The above results are consistent with the hypothesis that
alternate initiation sites present in Pitx2c mRNA give rise
to two, if not three, proteins by a context-dependent leaky
ribosomal scanning mechanism. Because the non-consen-
sus (Met1 and Met4) as well as consensus (Met35) nucle-
otides surrounding the different potential translation start
sites are conserved in mammals (Fig. 2A) and in species as
diverse as chicken and zebrafish (data not shown), we pre-
dict that the long and short forms of PITX2C are expressed
in other species, including humans. As mentioned above,
previously published, though not fully appreciated, data
similarly showed that two proteins, which we predict cor-
respond to PITX2Cα and PITX2Cβ, are produced from a
human PITX2C expression construct in CHO cells [23].
The cDNA sequence for murine Pitx2cβ has been depos-
ited in GenBank (acc. no. AM940439).
Alternative translation initiation sites are present in PITX2C mRNA Figure 2
Alternative translation initiation sites are present in PITX2C mRNA. A) Comparison of the nucleotides flanking the 
start codon (Met1) and two other in-frame candidate start codons (Met4 and Met35) in the Pitx2c/PITX2C mRNAs from vari-
ous mammalian species. The Kozak consensus sequence is shown at the top to facilitate the comparison. [GenBank accession 
nos. for the human: NM_000325, mouse: NM_001042502, rat: AJ222971, cow: NM_001097991, and dog: XM_846277]. B) 
Schematic representation of the expression constructs designed to study the two PITX2C isoforms. The large and small 
arrows represent strong and weak AUGSTART codons in each cDNA sequence. C) Immunoblot analysis showing the PITX2C 
protein isoforms translated from the expression constructs in panel B when transfected into CHO cells. Lysates were run on a 
10% Nupage® Novex Bis-Tris gel with MOPS buffer.
B
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Similar to what we observe here, there are many examples
in the literature of transcription factor mRNAs that pro-
duce short and long forms of the protein by context-
dependent leaky scanning (e.g. GATA1, Pit-1, C/EBPα,
EGR3, LHX3a [40-44]). As with alternative splicing and
multiple promoters, this mechanism permits biologically-
A Novel PITX2 mRNA splice variant Figure 3
A Novel PITX2 mRNA splice variant. A) Full-length Pitx2a, Pitx2b1, and Pitx2b2 cDNAs amplified by RT-PCR from LβT2 
mRNA. B) Schematic representation of the splicing events giving rise to Pitx2b1 (top) or Pitx2b2 (bottom). The 3' end of exon 
2 (donor) and 5' end of exon 3 are indicated in white type with black shading. Upper and lower case letters are used for exon 
and intron nucleotides, respectively. The components of the lariat for the 3' alternative acceptor site are shown, with a branch 
point (circled, with invariant A shown as bold and italicized), followed by a poly-pyrimidine tract (underlined) and a terminal 
AG (boxed) at the extreme 3' end. C) RT-PCR analysis of Pitx2a/PITX2A, Pitx2b1/PITX2B1 and Pitx2b2/PITX2B2 mRNAs in 
LβT2 cells, and murine and human pituitary. D) Immunoblot analysis of PITX2 isoforms expressed in LβT2 cells (left) and com-
bined nuclear extracts from CHO cells (right) transfected with different PITX2 isoforms run on 13.5% Tis-glycine SDS-PAGE 
gels. A, PITX2A; B1, PITX2B1; B2, PITX2B2; Cα, PITX2Cα; Cβ, PITX2Cβ.
A C
B
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relevant diversity in protein synthesis from individual
genes (for review, see [45]).
A Novel Pitx2/PITX2 mRNA variant produced through 
alternative splicing
Alternative pre-mRNA splicing gives rise to PITX2A and
PITX2B isoforms, with exon 3 being skipped in PITX2A
(Fig. 1). In the course of amplifying full-length Pitx2a and
Pitx2b  cDNAs from the murine gonadotrope cell line,
LβT2, we observed three, rather than the two expected
amplicons (data not shown). Repeating the RT-PCR with
DNased RNA, to remove potentially contaminating
genomic DNA, showed a similar pattern (Fig. 3A). We
cloned and sequenced all three products and confirmed
that the top and bottom bands corresponded to Pitx2b
(hereafter Pitx2b1) and Pitx2a, respectively. The middle
band contained a novel sequence (hereafter Pitx2b2),
highly related to Pitx2b1. Aligning Pitx2b2 with murine
Pitx2  genomic (on chromosome 3) and Pitx2b1  cDNA
sequences (GenBank accession nos. AC116740 and
U80010) revealed that it employs the same 5' splice donor
in the second intron as Pitx2a and Pitx2b1, but utilizes an
alternative 3' splice acceptor within exon 3 (Fig. 3B). As a
result, the first 39 bp of exon 3 are absent from this iso-
form. The PITX2B2 protein is predicted have 304 amino
acids, lacking the first 13 residues (amino acids 16 – 28)
encoded by exon 3, but otherwise being identical to
PITX2B1. Analysis of the sequence 5' to this novel accep-
tor site indicates the presence of consensus sequences for
the observed splicing event (Fig. 3B) [46,47]. Our litera-
ture search did not shed light on possible factors that
might regulate the alternative splicing choices [46]. We
confirmed Pitx2b2 expression by RT-PCR in murine pitui-
tary, indicating that this splicing event is not an artifact
restricted to the LβT2 cell line (Fig. 3C, left panel, lane 5).
The cDNA sequence for murine Pitx2b2 has been depos-
ited in GenBank (acc. no. AM940438).
We next examined whether PITX2B2 mRNA is also present
in human. RT-PCR of human pituitary mRNA demon-
strated the expression of PITX2A, PITX2B1, and PITX2B2
(Fig. 3C, right panel, lane 8). Examination of the PITX2
genomic sequence on human chromosome 4 (GenBank
accession nos. NM_153426 and NT_016354) confirmed
that the sequence permitting alternative splicing in
murine  Pitx2  (branch point, poly-pyrimidine tract fol-
lowed by a terminal AG) is also present in human PITX2.
However, the degeneracy of splicing regulatory sequence
makes it difficult to know this with certainty [47]. We
were unable to identify Pitx2b2/PITX2B2 in EST database
searches. This is not a major concern, as very few murine
ESTs in the NCBI database correspond to Pitx2b1, none of
which were derived from pituitary libraries. We confirmed
PITX2B2 protein expression in gonadotrope cell lines,
LβT2 and αT3-1 (Fig. 3D, left lane and data not shown).
Comparing the migration of the endogenous LβT2 pro-
teins (Fig. 3D, left lane) with a combination of nuclear
extracts from CHO cells transfected with expression vec-
tors for each murine PITX2 isoform (right) shows that the
PITX2B2 protein migrates just above PITX2Cβ. Indeed,
the predicted molecular weight of PITX2B2 (304 aa, ~34.0
KDa) is only slightly greater than that of PITX2Cβ (290 aa,
~32.2 kDa). Thus, the two proteins can be resolved only
when separated on high percentage polyacrylamide gels
(≥ 13.5%) (Fig. 3D). When run on lower percentage gels
(e.g., as in Figs. 4A and 4B), PITX2Cβ and PITX2B2 run so
closely together as to appear as one abundant protein.
PITX2 can be post-translationally modified (e.g., by phos-
phorylation, [7,48]); therefore, it is possible that the dif-
ferent isoforms we observe in LβT2 cells extracts might
represent fewer isoforms than suggested, but with differ-
ent states of post-translational modification. Given that
the bands observed by over-expression in CHO cells show
the same migration patterns and can be directly attributed
to the proposed isoforms, we consider this a less likely
explanation for the observed data. This does not preclude
the fact that the distinct isoforms may be differentially
post-translationally modified by virtue of their unique
sequences. Indeed, the 34 additional amino acids in
PITX2Cα include residues potentially subject to modifica-
tion (i.e., Lys5, Thr17, Lys18, Ser20, Ser23, Ser24, and
Cys27). Three residues in the 13 amino acids unique to
PITX2B1 (i.e., Cys24, Ser 27, and Lys28) might also be
modified. These possibilities should be addressed in
future analyses.
Identification of the major PITX2 isoforms expressed in 
LβT2 cells and adult murine pituitary
The major protein isoforms of PITX2 in mammals are gen-
erally considered to be PITX2A (271 aa), PITX2B1 (317
aa) and PITX2Cα (324 aa). In light of our results, we re-
examined this hypothesis. The endogenous proteins
expressed in LβT2 cells (Fig. 4A, nuclear and whole cell
extracts, lanes 8 and 9) and adult murine pituitary (whole
cell extract, lane 10) were compared with the different iso-
forms expressed in CHO cells; PITX2A (lane 2), PITX2B1
(lane 3), WT PITX2C (lane 4), PITX2Cα (M35L, lane 5),
PITX2Cβ (L5Stop, lane 6), and PITX2A and WT PITX2C
together (lane 7). The results suggest that: 1) the major
forms in homologous cells/tissues are PITX2A, PITX2Cα
and PITX2Cβ, 2) PITX2Cβ is not an artifact of our expres-
sion system and corresponds to the major immunoreac-
tive band that migrates intermediate to PITX2A and
PITX2Cα (compare lanes 6 and 8–10), and 3) endog-
enous PITX2B1 is expressed at relatively low levels and
migrates just below PITX2Cα (compare lanes 3 and 8–
10). The relative migration patterns of the different iso-
forms on SDS-PAGE are consistent with their predicted
molecular mass: PITX2A (271 aa, ~30.3 kDa), PITX2CβBMC Molecular Biology 2008, 9:31 http://www.biomedcentral.com/1471-2199/9/31
Page 7 of 15
(page number not for citation purposes)
The major PITX2 isoforms in gonadotrope cells, pituitary and skeletal muscle Figure 4
The major PITX2 isoforms in gonadotrope cells, pituitary and skeletal muscle. A) Immunoblot analysis of PITX2 
protein expression in CHO cells transfected with different PITX2 isoforms, LβT2 cells, and murine pituitary run on a 12% 
Nupage® Novex Bis-Tris gel with MOPS buffer. Abbreviations: pcDNA3.0, control; A, PITX2A; B1, PITX2B1; C, PITX2C; Cα, 
PITX2Cα; Cβ, PITX2Cβ; A+C, PITX2A and PITX2C; nuc, nuclear extract; WCE, whole cell extract. B) PITX2 immunoblot of 
murine skeletal muscle (Sk. mus.) WCE (lane 1), and LβT2 and αT3-1 nuclear extracts (lane 2 and 3) run on a Nupage® Novex 
7% Tris-acetate gel. C) RT-PCR analysis of Pitx2a, Pitx2b1 and Pitx2b2 (top) and Pitx2c (middle) mRNA in LβT2 cells and murine 
skeletal muscle (hindlimb). Rpl19 (bottom) was used as a loading control.
B
A
CBMC Molecular Biology 2008, 9:31 http://www.biomedcentral.com/1471-2199/9/31
Page 8 of 15
(page number not for citation purposes)
(290 aa, ~32.2 kDa), PITX2B1 (317 aa, ~35.3 kDa) and
PITX2Cα (324 aa, ~35.8 kDa). Note that the gel in this fig-
ure was not of a sufficiently high percentage to resolve
PITX2Cβ and PITX2B2. In addition, based on the data in
Fig. 3D, we cannot rule out the possibility that these latter
two isoforms are expressed at equivalent levels in LβT2
cells and pituitary.
These data indicate that previous assessments of relative
PITX2B1 protein levels were likely over-estimated. That is,
three prominent bands typically detected by immunoblot
using PITX2 antisera were attributed to PITX2A, PITX2B,
and PITX2C [31]. Our data show that these are PITX2A,
PITX2Cβ (and/or PITX2B2, co-migrating with each
other), and PITX2Cα. Thus, what was previously inter-
preted as PITX2B1 is PITX2Cβ (and perhaps PITX2B2),
and that PITX2B1 is of low abundance and is only slightly
smaller than PITX2Cα (as would be predicted by the pri-
mary amino acid sequence).
These observations become particularly relevant in cellu-
lar contexts where only some of the PITX2 protein iso-
forms are expressed. For example, as shown in Fig. 4B, a
single PITX2 immunoreactive band is observed in skeletal
muscle (lane 1). PITX2 has been demonstrated to be
expressed in virtually all embryonic anlagen and adult
muscle groups, suggesting that the protein(s) may play
some role in maturation or maintenance of muscle anla-
gen [49]. Previously, this protein might have been attrib-
uted to PITX2B1; however, comparing its migration to
proteins in gonadotrope cell lines (Fig. 4B, lane 2 and 3)
strongly suggests that it is PITX2Cβ. Indeed, we detect
Pitx2c (Fig. 4C, middle panel, lane 3) mRNA in the skele-
tal muscle. Unlike the case with gonadotrope cells, we
only detect one isoform on the immunoblot, raising the
possibility that this protein may correspond to PITX2Cβ
or PITX2B2. However, we did not detect Pitx2b1 or Pitx2b2
mRNAs in skeletal muscle and Pitx2a  mRNA was
expressed at low levels, suggesting that the upstream pro-
moter is relatively inactive in this tissue in adult mice (Fig.
4C, upper panel, lane 3). We have observed that the
PITX2Cα isoform may be more labile than the PITX2Cβ
isoform (e.g., Fig. 4A, lane 4, and data not shown) and
this may account for its apparent absence in skeletal mus-
cle (Fig. 4B, lane 1). This might also be predicted based on
differences between the two proteins in amino acids that
confer metabolic instability.
The N-end rule, which relates the in vivo half-life of a pro-
tein to the identity of its N-terminal residue, predicts that
PITX2Cβ would be more stable, as it has the stabilizing
amino acid, alanine, at its N-terminus. In contrast,
PITX2Cα has the tertiary destabilizing N-terminal residue
asparagine. Our data do not definitively rule out the pos-
sibility that PITX2Cα might initiate from Met4. However,
this protein would also be more labile due to the primary
destabilizing N-terminal residue, lysine [50,51]. Our
results lend support to the recent reclassification of
alanine from a type 3 primary destabilizing residue to a
stabilizing amino acid under the mammalian N-end rule
[51].
All PITX2 isoforms trans-activate gonadotrope-restricted 
gene promoters
PITX2 isoforms differ in their N-termini, and this contrib-
utes to variation in their trans-activation functions in
some contexts [23]. As all PITX2 isoforms are expressed in
gonadotrope cells, we compared their relative abilities to
trans-activate gonadotrope-restricted genes: A) murine
Fshb (mFshb), B) bovine Lhb (bLhb), C) murine gonado-
tropin-releasing hormone receptor (mGnrhr), and D)
bovine chorionic gonadotropin α subunit (bCga). All of
these promoters were shown previously to be stimulated
by different PITX proteins in heterologous cells [27,32,52-
54]. We transfected CV-1 cells (a heterologous monkey
kidney cell line that was used previously in similar studies
[27,32,52,53]) with the indicated reporters and PITX2
expression vectors.
The novel PITX2B2 and PITX2Cβ isoforms stimulated all
of the gonadotrope-restricted gene promoters. PITX2B2
was more potent in stimulating the mFshb  promoter-
reporter compared to PITX2A, which was in turn more
potent than PITX2B1 (Fig. 5A). PITX2B2 was more effi-
ciently expressed in CV-1 cells than the PITX2A or B1 iso-
forms (Fig. 5E) [this was not the case in CHO cells, see Fig.
7A], which might account for its greater trans-activation
function. These data and their statistical analysis should
be considered in this light. This concern does not, how-
ever, account for the differences between PITX2A and B1,
which were expressed equivalently. PITX2B1 was also less
effective in trans-activating the mGnrhr and bCga promot-
ers compared to PITX2A and PITX2B2, which did not dif-
fer (Figs. 5C and 5D). We next compared the actions of
PITX2Cα, PITX2Cβ, and PITX2C WT (which produces
both forms). PITX2Cβ was more potent in stimulating
mFshb transcription compared to PITX2Cα (Fig. 6A) even
though they were expressed equivalently in CV-1 cells
(Fig. 6E). PITX2Cα and PITX2Cβ similarly stimulated
transcription of mGnrhr and bCga (Fig. 6C and 6D). All
the PITX2 isoforms similarly synergized with SF-1
(NR5A1) to potently regulate bLhb transcription (Figs. 5B
and 6B). These latter results were similar to those from a
previous report, which demonstrated synergism between
PITX2A or PITX2B1 and SF-1 on the bLhb promoter in CV-
1 cells [27].
We next examined DNA binding by PITX2B2 and
PITX2Cβ proteins. We demonstrated that PITX2 proteins
exert their actions through a conserved cis-element,BMC Molecular Biology 2008, 9:31 http://www.biomedcentral.com/1471-2199/9/31
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PITX2A, PITX2B1 and PITX2B2 isoforms trans-activate gonadotrope-specific genes Figure 5
PITX2A, PITX2B1 and PITX2B2 isoforms trans-activate gonadotrope-specific genes. A, C and D) CV-1 cells 
seeded in 12-well plates were co-transfected with the indicated promoter-reporters (0.9 µg/well) along with empty 
(pcDNA3.0) or PITX2 expression vectors (0.3 µg/well). B) The Lhb promoter-reporter (0.9 µg/well) was co-transfected with 
PITX2 expression vectors plus or minus SF-1 (both expression vectors at 0.3 µg/well; DNA in all wells was balanced with 
pcDNA3.0). After approximately 30 h, lysates were collected for luciferase assays. Data were derived from three to five exper-
iments performed in triplicate. Bars with different symbols differ significantly. E) Immunoblot showing relative PITX2A, B1 and 
B2 expression in CV-1 cells, whole cell extracts run on a 4–12% Nupage® Novex Bis-Tris gel with MOPS buffer.
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Trans-activation of gonadotrope-specific genes by PITX2C isoforms Figure 6
Trans-activation of gonadotrope-specific genes by PITX2C isoforms. CV-1 cells were transfected as in Figure 5, 
except with PITX2C expression vectors [PITX2C, expressing both forms; PITX2Cα (M35L/T-3A); PITX2Cβ (L5stop)]. Immu-
noblot in panel E shows relative PITX2Cα and β expression in the transfected CV-1 cells (gel conditions as in Fig. 5E).
A B
C D
-780/+10 bLhb-luc
p
F
o
l
d
 
s
t
i
m
u
l
a
t
i
o
n
† 



 

†
†

 

ȕ Į
-199/+1 mFshb-luc
p
F
o
l
d
 
s
t
i
m
u
l
a
t
i
o
n

†

ȕ Į
-1772/+38 mGnrhr-luc
p
F
o
l
d
 
s
t
i
m
u
l
a
t
i
o
n
†
†
†
ȕ Į
-313/+48 bCga-luc
p
F
o
l
d
 
s
t
i
m
u
l
a
t
i
o
n
†
† †
ȕ Į
EBMC Molecular Biology 2008, 9:31 http://www.biomedcentral.com/1471-2199/9/31
Page 11 of 15
(page number not for citation purposes)
AAATCC, in the murine Fshb promoter [32]. All PITX2
isoforms bound to this element, but did so with appar-
ently differing affinities (Fig. 7B), given their comparable
levels of expression (Fig. 7A). We also conducted gel shifts
with probes containing putative PITX elements from the
bLhb, bCga and mGnrhr promoters [55,56]. All of the
PITX2 isoforms bound to the bLhb probe [see Additional
file 1(A)], but we failed to identify/confirm binding ele-
ments within the bCga and mGnrhr promoters under our
gel shift conditions (data not shown). The PITX2 isoforms
show two complexes with bLhb probe [see Additional file
1(A)] similar to what was observed earlier by Cox et al.
with the Dlx2 bicoid consensus sequence [23]. It is possi-
ble that the two complexes reflect PITX2 binding alone
(monomer and dimer) or with a non-PITX partner
expressed endogenously in CHO cells. As an added con-
trol, we examined the binding of the PITX2 isoforms to
the recognized PITX binding element (CE3) in the rat
Pomc promoter [4] and observed a binding pattern simi-
lar to that with the mFshb probe [see Additional file 1(B)].
Collectively, the data show that all PITX2 isoforms exam-
ined here can stimulate transcription of gonadotrope-
restricted promoter-reporters, though their relative effects
can vary between genes. This is in agreement with results
of previous studies [8,23,28,54]. In some instances (e.g.,
murine Fshb), this may be related to differences in relative
binding affinities, whereas additional/alternative mecha-
nisms, including differences in their expression levels in
CV-1 cells or post-translational modifications of the pro-
teins [7,48] may be at play in other cases.
Conclusion
Here, we identified two novel forms of PITX2, produced
by alternative mRNA splicing (PITX2B2) and alternative
translation initiation (PITX2Cβ). Endogenous protein
All PITX2 isoforms bind the Fshb promoter Figure 7
All PITX2 isoforms bind the Fshb promoter. A) Immunoblot showing PITX2 isoforms over-expressed in CHO cell 
extracts run on 10% Nupage® Novex Bis-Tris gel with MOPS buffer. B) Gel shift assay performed with a radio-labeled probe 
corresponding to -61/-40 of the murine Fshb promoter with the same nuclear extracts used in panel A. The free probe is not 
pictured and lanes are numbered at the bottom.
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expression of both forms was confirmed in gonadotrope
cell lines (PITX2B2 and PITX2Cβ) and murine pituitary
and skeletal muscle (PITX2Cβ). Based on the protein and
mRNA data, we suggest that the preferred splicing event is
removal of exon 3, generating Pitx2a. When exon 3 is
included, the splicing events generating Pitx2b1  and
Pitx2b2 mRNAs are roughly equivalent, at least in pitui-
tary. Our results are consistent with earlier reports demon-
strating lower abundance of Pitx2b1  relative to Pitx2a
mRNAs in human and murine pituitary as well in various
cell lines representing different pituitary cell types [5,35].
PITX2Cβ is not only abundant, but appears to be the pro-
tein previously attributed to PITX2B1. Though, our results
suggest that PITX2Cβ abundance might also be over-esti-
mated because PITX2B2 migrates with this isoform and
only higher percentage gels can faithfully resolve the two
proteins.
A comparison of the trans-activation functions of the
PITX2C isoforms showed that both stimulated various
gonadotrope-specific genes in a qualitatively similar man-
ner, though quantitatively to different extents in some cir-
cumstances. The conservation of these isoforms across
species suggests that they may play distinct biological
roles, perhaps independent of their roles as transcription
factors, that we were unable to uncover fully here. Knock-
in studies in mice introducing the mutations we describe
would enable exclusive expression of the two isoforms
and provide a means to assess their relative roles during
development (e.g., left and right patterning) and adult-
hood.
Methods
Reagents
Dulbecco's modified Eagle medium (DMEM) with 4.5 g/
L glucose, L-glutamine and sodium pyruvate was from
Mediatech (Herndon, VA). Fetal bovine serum (FBS) and
bovine calf serum (BCS) were bought from JRH Bio-
sciences (Lenexa, KS). F-12/DME (1:1) medium with 1.4
g/L glucose, L-glutamine without linolenic acid was from
Irvine Scientific (Santa Ana, CA). Aprotinin, leupeptin,
pepstatin and PMSF were from Sigma (St. Louis, MO).
Restriction endonucleases, RQ1 DNase, T4 polynucle-
otide kinase, deoxynucleotide triphosphates, Moloney
murine leukemia virus reverse transcriptase, random
primer hexamers, Taq polymerase and 5× Passive Lysis
Buffer (PLB) were from Promega (Madison, WI). Pfu-
Turbo DNA polymerase was from Stratagene (La Jolla,
CA). Primers and probes (Table 1) were synthesized by
IDT (Coralville, IA). Poly(dI).poly(dC) and ECL-plus rea-
gent were purchased from Amersham Biosciences (Piscat-
away, NJ).
Animals
The indicated tissues were extracted from male wild-type
CD1 mice in accordance with institutional (Rockefeller
University and McGill University) and federal guidelines.
Table 1: Primer and probe sequences
Cloning
Pitx2a/b.forward 5' CGTACGAAGCTTATGGAGACCAATTGTCGCAAAC 3'
Pitx2c.forward 5' CGGGATCCTCCATGAACTGCATGAAAGGC 3'
Pitx2.reverse 5' AGTTGCCCACTCCGACAGTCCT 3'
Mutagenesis (sense strand)
Pitx2c.M35L 5' CATCCCCAGGCGTTAGCCTTAGCTTCGGTCCTAGCTCCTG 3'
Pitx2c.L5stop 5' CTCCATGAACTGCATGTAAGGCCCGCTGCCCTTG 3'
Pitx2c.T-3A 5' CGATTCGGGATCCACCATGAACTGCATG 3'
Oligonucleotide probes for colony hybridization
P1 probe 5' CCAGCAGCAAGCTGTTCCCGCGGCAGCACCCC 3'
P2 probe 5' GCCGGCAGCCGTTGAATGTCTCTTCTCC 3'
RT-PCR
Pitx2a/b.forward 5' CGTACGAAGCTTATGGAGACCAATTGTCGCAAAC 3'
Pitx2.reverse 5' AGTTGCCCACTCCGACAGTCCT 3'
Pitx2c.forward 5' CGGGATCCTCCATGAACTGCATGAAAGGC 3'
Pitx2.HD.reverse 5' TCGGGCTTCCGTAAGGTTGGTC 3'
Rpl19.forward 5' CTGAAGGTCAAAGGGAATGTG 3
Rpl19.reverse 3' GGACAGAGTCTTGATGATCTC 3'
EMSA (sense strand)
-61/-40 mFshb 5' CACCCAGTAAATCCACAGGGTT 3'
CE3 rPomc 5' ACCAGGATGCTAAGCCTCTCGTC 3'
-106/-76 bLhb 5' GCCCCCGGGGAGATTAGTGTCCAGGTTACCCCACC 3'
-321/-280 mGnrhr 5' TCATTAAGGCTAATTGGATGATATTATGAGTCACTTTCGACA 3'
-406/-365 mGnrhr 5' TTTTAAATTGGATCGGGATTTTTAAATTACTTTTCTGTATTT 3'
-100/-68 bCga 5' GGGTGGAATTTACTGTTGATCCCTGGACTTAGA 3'
Identified or known PITX binding cis-elements are underlined in the EMSA probesBMC Molecular Biology 2008, 9:31 http://www.biomedcentral.com/1471-2199/9/31
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Reporter and expression constructs
The open reading frame (ORF) of the murine Pitx2 iso-
forms: Pitx2a, Pitx2b1, Pitx2c and Pitx2b2 were PCR-ampli-
fied from LβT2 cell cDNA using previously described
methods [57]. Reverse primer directed against the 3'UTR,
Pitx2.reverse, was used with isoform specific forward
primers (see Table 1). Amplified fragments were ligated
into pcDNA3.0 (Invitrogen) and verified by DNA
sequencing (Genewiz; South Plainfield, NJ). Site-directed
mutagenesis was used to generate different PITX2C
expression constructs from the parental wild-type vector
(primers are listed in Table 1).
-199/+1 murine Fshb-luc was described before [32]. -780/
+10 bovine Lhb-luc and -313/+48 bovine Cga-CAT were
kindly provided by Dr. John Nilson (Washington State
University, Pullman, WA) and -1772/+38 murine Gnrhr-
luc by Dr. Teresa Woodruff (Northwestern University,
Evanston, IL). The HindIII-HindIII fragment from -313/
+48 bCga-CAT in pSOVCAT was ligated into the same site
of pGL3-Basic (Invitrogen). The proper orientation was
confirmed by sequencing. All of the promoter-reporters
were in pGL3-Basic, except bLhb-luc, which was in pGL2-
Basic.
Cell culture, transfections and reporter assays
LβT2 and αT3-1 cells were provided by Dr. Pamela Mellon
(University of California, San Diego, CA) and were cul-
tured as described previously [32,58]. CHO and CV-1 cell
lines were obtained from Dr. Patricia Morris (Population
Council, New York, NY). CHO cells were cultured in F-12/
DME containing 5% horse (Gibco/Life Technologies) and
2.5% BCS. CHO cells in 10-cm dishes were transfected
when 70–80% confluent using Lipofectamine and 8 µg of
the indicated PITX expression vector. CV-1 cells were cul-
tured in DMEM/10% FBS. Prior to transfection, cells were
seeded in 12-well plates at a density of 3 × 104 cells per
well and ~36 h later were transfected using the calcium-
phosphate method [59]. Briefly, DNA was diluted in 0.1×
TE (pH 7.6) and CaCl2 [0.25 M final]. One volume of this
2× CaCl2-DNA solution was mixed with an equal volume
of 2× HEPES-buffered saline [140 mM NaCl, 10 mM KCl,
1.5 mM Na2HPO4.2H20, 50 mM HEPES (pH 7.05)]. The
DNA-CaPO4 mixtures were incubated for 1 min at room
temperature prior to adding to the cells. After 6–8 h, the
medium was replaced and 24 h later the cells were washed
with phosphate-buffered saline (PBS) and lysed in 1× PLB
(Promega). Luciferase assays were performed on a Lumi-
noskan Ascent luminometer (Thermo Labsystems, Frank-
lin, MA) using standard reagents.
Immunoblot assays
Whole cell extracts from the gonadotrope cell line, LβT2
and αT3-1, and nuclear protein extracts from CHO cells
transfected with PITX2 expression vectors were prepared
as previously described [32]. Protein extract from skeletal
muscle (hindlimb) was prepared by grinding frozen tissue
with mortar and pestle. One ml of RIPA buffer was added
for every 100 mg of tissue. Further, tissue was frozen in
liquid nitrogen and thawed (37 C) six times in buffer and
finally centrifuged at 13,000 × g for one hour at 4 C to
remove cellular debris. Immunoblots were performed
using previously described methods [60]. The PITX2 anti-
body (P2Y4) was raised in rabbit against an epitope
(DPSKKKR) N-terminal to the homeodomain, as previ-
ously described for the P2R10 antibody. This antibody
recognizes all the known PITX2 protein isoforms in
human, mouse and Xenopus [23,61], except PITX2D.
Colony hybridization
The same PCR primers were used to generate expression
vectors for PITX2A, PITX2B2, and PITX2B2. Recombinant
clones were screened by colony hybridization to identify
the different isoforms. Briefly, colony lifts were performed
using Protran nitrocellulose membranes (Schleicher &
Schuell, Keene, NH). Membranes were sequential incu-
bated in denaturation [1.5 M NaCl, 0.5 M NaOH], neu-
tralizing [0.5 M Tris-HCl (pH 8), 1.5 M NaCl], and wash
buffers [0.2 M Tris-HCl (pH 7.5), 2× SSC]. DNA was cross-
linked to the membrane using a UV cross-linker (Strata-
linker 1800; La Jolla, CA). Single-stranded oligonucle-
otides designed to differentiate Pitx2b1 and Pitx2b2 from
Pitx2a clones (P1) and Pitx2b1 from Pitx2b2 clones (P2)
were end-labeled with 32P-ATP (Perkin Elmer; Waltham,
MA) using T4 polynucleotide kinase (Table 1). Duplicate
membranes were probed with 2 × 106 cpm/ml of the P1 or
P2 probes at 42 C overnight. After washing, blots were
apposed to X-ray film. Differing hybridization patterns
between the two probes were used to isolate Pitx2b1 and
Pitx2b2 clones. Clones were validated by restriction digest
and sequencing.
Reverse transcription-polymerase chain reaction (RT-
PCR)
Total RNA from LβT2 cells and murine pituitary and skel-
etal muscle (hindlimb) was prepared using TRIzol (Invit-
rogen) following manufacturer's instructions. Human
pituitary (normal adult) RNA was from BioChain Insti-
tute, Inc. (Hayward, CA). Pitx2a, Pitx2b1 and  Pitx2b2
mRNA expression in LβT2 cells, murine and human pitu-
itaries and murine skeletal muscle was examined by RT-
PCR using the Pitx2a/b.forward and Pitx2HD.reverse or
Pitx2.reverse primers (Table 1) and previously described
methods [57]. These primers matched both murine and
human sequences. Pitx2c  mRNA was detected using
Pitx2c.forward and Pitx2HD.reverse primers. The PCR
cycling profile using Taq polymerase (Promega) consisted
of an initial denaturation step at 94 C for 2 min followed
by 35 – 40 cycles of amplification (94 for 30 sec, 55 for 30
sec and 72 for 30 sec). After PCR, the amplified productsBMC Molecular Biology 2008, 9:31 http://www.biomedcentral.com/1471-2199/9/31
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were subjected to electrophoresis on 2% agarose gels
stained with ethidium bromide.
Electrophoretic mobility shift assays
Gel shift experiments were performed using nuclear
extracts form PITX2-transfected CHO cells as described
previously [32] with the following modifications: 0.5–1
µg poly(dI).poly(dC) was used in the binding buffer as
non-specific competitor. The gel shift with -106/-76 bLhb
probe used 0.5 µg salmon-sperm DNA. Gels were run for
2.5–3 h at 4 C.
Statistics
Data from replicate experiments were pooled (n = 9 or 15
per treatment) for statistical analyses and are presented as
fold-change from the control condition (set to 1) in each
experiment. Differences between means were compared
using one- or two-way analyses of variance (ANOVA), fol-
lowed by Tukey post-hoc tests where appropriate (Systat
10.2, Richmond, CA). In some experiments, data were log
transformed when the variances were unequal between
groups. Significance was assessed relative to p < 0.05.
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